Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)

v3.21.4
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
Class A Ordinary Shares
Class B Ordinary Shares
Ordinary Shares
Class B Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020   $ 863   $ 24,137 $ (5,000) $ 20,000
Balance at the beginning (in shares) at Dec. 31, 2020   8,625,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Sale of 6,466,666 Private Placement Warrants       194,001   194,001
Accretion to shares subject to redemption       (218,138) (35,283,847) (35,501,985)
Net income (loss)         13,418,851 13,418,851
Balance at the end at Mar. 31, 2021   $ 863     (21,869,996) (21,869,133)
Balance at the end (in shares) at Mar. 31, 2021   8,625,000        
Balance at the beginning at Dec. 31, 2020   $ 863   $ 24,137 (5,000) 20,000
Balance at the beginning (in shares) at Dec. 31, 2020   8,625,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 10,162,713   $ 3,085,434     13,248,147
Balance at the end at Sep. 30, 2021   $ 863     (22,040,700) (22,039,837)
Balance at the end (in shares) at Sep. 30, 2021   8,625,000        
Balance at the beginning at Mar. 31, 2021   $ 863     (21,869,996) (21,869,133)
Balance at the beginning (in shares) at Mar. 31, 2021   8,625,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss)         (5,197,686) (5,197,686)
Balance at the end at Jun. 30, 2021   $ 863     (27,067,682) (27,066,819)
Balance at the end (in shares) at Jun. 30, 2021   8,625,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 4,021,586   $ 1,005,396   5,026,982 5,026,982
Balance at the end at Sep. 30, 2021   $ 863     $ (22,040,700) $ (22,039,837)
Balance at the end (in shares) at Sep. 30, 2021   8,625,000